This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Koukkari, M. W. Articles by Guarino, E. J. Search for Related Content PubMed PubMed Citation Articles by Koukkari, M. W. Articles by Guarino, E. J. Social Bookmarking                         What's this?

Retrospective Study of the Use of Levetiracetam in Childhood Seizure Disorders

Department of Pediatrics, O'Connor Hospital San Jose, CA, mkoukkari{at}aol.com

Edward J. Guarino, MD

Department of Pediatrics, O'Connor Hospital San Jose, CA

The purpose of this study was to assess the efficacy and safety of levetiracetam in a diverse pediatric epilepsy population. A retrospective chart review of 52 consecutive children age 8 months to 16 years who were treated with levetiracetam was performed. The data include patients with partial and generalized seizures, monotherapy, and concomitant antiepileptic drug use. Levetiracetam was dosed to efficacy or unacceptable side effects, with a range of 8 to 315 mg/kg/day. Two patients discontinued levetiracetam prior to assessment of efficacy owing to side effects. Of the remaining 50 patients, 12 had 75% seizure reduction, 3 had 50% and < 75% seizure reduction, 8 had 25% and < 50% seizure reduction, and 27 had < 25% seizure reduction. A variety of pediatric epilepsy syndromes and seizure types were represented. Adverse events, seen in 17 patients, were determined to be tolerable or resolved over time with continued dosing, dosage reduction, or discontinuation. This open-label, retrospective study of 52 consecutive pediatric patients treated with levetiracetam indicates at least partial efficacy in a variety of pediatric epilepsy syndromes. Tolerability was surprisingly favorable, even at doses far exceeding 40 mg/kg/day. ( J Child Neurol 2004;19:944—947).

Journal of Child Neurology, Vol. 19, No. 12, 944-947 (2004)
DOI: 10.1177/08830738040190120601


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. Krief, Li Kan, and J. Maytal Efficacy of Levetiracetam in Children With Epilepsy Younger Than 2 Years of Age J Child Neurol, May 1, 2008; 23(5): 582 - 584. [Abstract] [PDF]

				S. Perry, P. Holt, and M. Benatar Levetiracetam Versus Carbamazepine Monotherapy for Partial Epilepsy in Children Less Than 16 Years of Age J Child Neurol, May 1, 2008; 23(5): 515 - 519. [Abstract] [PDF]